Iterum Therapeutics plc (ITRMF) Preferred Stock Liabilities (2017)
Iterum Therapeutics (ITRMF) posted quarterly Preferred Stock Liabilities of $30000.0 for Q4 2017.
Iterum Therapeutics plc (ITRMF) Preferred Stock Liabilities (2017) Analysis & Trends
Iterum Therapeutics' Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $30000.0 for Q4 2017.
- In Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $30000.0; the TTM figure through Dec 2017 stood at $30000.0 (changed N/A YoY), while the FY2017 annual figure was $30000.0, changed N/A from the prior year.
- Preferred Stock Liabilities for Q4 2017 stood at $30000.0.
- The five-year high for Preferred Stock Liabilities was $30000.0 in Q4 2017, with the low at $30000.0 in Q4 2017.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 30,000.00 |